Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.

On respiratory impairment in cancer cells.

WARBURG O.

Science. 1956 Aug 10;124(3215):269-70. No abstract available.

PMID:
13351639
2.

[Molecular mechanism regulating effect of anti-cancer agents].

Saya H.

Gan To Kagaku Ryoho. 2009 Jan;36(1):1-5. Review. Japanese.

PMID:
19151557
3.

ROS stress in cancer cells and therapeutic implications.

Pelicano H, Carney D, Huang P.

Drug Resist Updat. 2004 Apr;7(2):97-110. Review.

PMID:
15158766
4.

Markers in normal and cancer stem cells.

Natarajan TG, FitzGerald KT.

Cancer Biomark. 2007;3(4-5):211-31. Review.

PMID:
17917151
5.

Cytokines and their relationship to the symptoms and outcome of cancer.

Seruga B, Zhang H, Bernstein LJ, Tannock IF.

Nat Rev Cancer. 2008 Nov;8(11):887-99. doi: 10.1038/nrc2507. Epub 2008 Oct 10. Review.

PMID:
18846100
6.

Centrosomes and cancer: how cancer cells divide with too many centrosomes.

Godinho SA, Kwon M, Pellman D.

Cancer Metastasis Rev. 2009 Jun;28(1-2):85-98. doi: 10.1007/s10555-008-9163-6. Review.

PMID:
19156503
7.

Mitochondria-targeting therapeutic strategies for overcoming chemoresistance and progression of cancer.

Morisaki T, Katano M.

Curr Med Chem. 2003 Dec;10(23):2517-21. Review.

PMID:
14529467
8.

A self-renewal assay for cancer stem cells.

Clarke MF.

Cancer Chemother Pharmacol. 2005 Nov;56 Suppl 1:64-8. Review.

9.
10.

Wnt signalling in stem cells and cancer.

Reya T, Clevers H.

Nature. 2005 Apr 14;434(7035):843-50. Review.

PMID:
15829953
11.

Glucose avidity of carcinomas.

Ortega AD, Sánchez-Aragó M, Giner-Sánchez D, Sánchez-Cenizo L, Willers I, Cuezva JM.

Cancer Lett. 2009 Apr 18;276(2):125-35. doi: 10.1016/j.canlet.2008.08.007. Epub 2008 Sep 14. Review.

PMID:
18790562
12.

Digitoxin as an anticancer agent with selectivity for cancer cells: possible mechanisms involved.

López-Lázaro M.

Expert Opin Ther Targets. 2007 Aug;11(8):1043-53. Review.

PMID:
17665977
13.

Mitochondria and human cancer.

Modica-Napolitano JS, Kulawiec M, Singh KK.

Curr Mol Med. 2007 Feb;7(1):121-31. Review.

PMID:
17311537
14.

Recent advances in cancer stem cells.

Cho RW, Clarke MF.

Curr Opin Genet Dev. 2008 Feb;18(1):48-53. doi: 10.1016/j.gde.2008.01.017. Epub 2008 Mar 19. Review.

PMID:
18356041
15.

Aneuploidy, stem cells and cancer.

Pathak S, Multani AS.

EXS. 2006;(96):49-64. Review.

PMID:
16383014
16.

Killing cancer cells by flipping the Bcl-2/Bax switch.

Cory S, Adams JM.

Cancer Cell. 2005 Jul;8(1):5-6. Review.

17.

Cancer stem cells: redefining the paradigm of cancer treatment strategies.

Dean M.

Mol Interv. 2006 Jun;6(3):140-8. Review.

PMID:
16809475
18.

Cancer stem cells and their niche.

Iwasaki H, Suda T.

Cancer Sci. 2009 Jul;100(7):1166-72. doi: 10.1111/j.1349-7006.2009.01177.x. Epub 2009 Apr 22. Review.

19.

The significance of cancer cell expression of the chemokine receptor CXCR4.

Balkwill F.

Semin Cancer Biol. 2004 Jun;14(3):171-9. Review.

PMID:
15246052
20.

Downregulation of gap junctions in cancer cells.

Leithe E, Sirnes S, Omori Y, Rivedal E.

Crit Rev Oncog. 2006 Dec;12(3-4):225-56. Review.

PMID:
17425504

Supplemental Content

Support Center